Objective: To investigate the efficacy and mechanism of ultrasound-targeted microbubble destruction (UTMD) combined with radiotherapy (XRT) on glioblastoma.

Methods: The enhanced radiosensitization by UTMD was assessed through colony formation and cell apoptosis in Human glioblastoma cells (U87MG). Subcutaneous transplantation tumors in 24 nude mice implanted with U87MG cells were randomly assigned to 4 different treatment groups (Control, UTMD, XRT, and UTMD + XRT) based on tumor sizes (100-300 mm). Tumor growth was observed for 10 days after treatment, and then histopathology stains (HE, CD34, and γH2AX) were applied to the tumor samples. A TUNEL staining experiment was applied to detect the apoptosis rate of mice tumor samples. Meanwhile, tissue proteins were extracted from animal specimens, and the expressions of dsDNA break repair-related proteins from animal specimens were examined by the western blot.

Results: When the radiotherapy dose was 4 Gy, the colony formation rate of U87MG cells in the UTMD + XRT group was 32 ± 8%, lower than the XRT group (54 ± 14%, p < 0.01). The early apoptotic rate of the UTMD + XRT group was 21.1 ± 3% at 48 h, higher than that of the XRT group (15.2 ± 4%). The tumor growth curve indicated that the tumor growth was inhibited in the UTMD + XRT group compared with other groups during 10 days of observation. In TUNEL experiment, the apoptotic cells of the UTMD + XRT group were higher than that of the XRT group (p < 0.05). The UTMD + XRT group had the lowest MVD value, but was not significantly different from other groups (p > 0.05). In addition, γH2AX increased due to the addition of UTMD to radiotherapy compared to XRT in immunohistochemistry (p < 0.05).

Conclusions: Our study clearly demonstrated the enhanced destructive effect of UTMD combined with 4 Gy radiotherapy on glioblastoma. This could be partly achieved by the increased ability of DNA damage of tumor cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021517PMC
http://dx.doi.org/10.1007/s00432-021-03542-5DOI Listing

Publication Analysis

Top Keywords

ultrasound-targeted microbubble
8
microbubble destruction
8
colony formation
8
u87mg cells
8
tumor samples
8
animal specimens
8
destruction enhance
4
enhance radiotherapy
4
radiotherapy glioblastoma
4
glioblastoma objective
4

Similar Publications

: To assess the anticancer effect of microbubbles (MBs) in combination with sinoporphyrin sodium (DVDMS)-mediated sonodynamic therapy (SDT) for the in vitro and in vivo treatment of hepatocellular carcinoma (HCC). : HepG2 cells were used for in vitro experiments. Reactive oxygen species (ROS) production was detected using 2',7'-dichlorodihydrofluorescein diacetate and singlet oxygen sensor green in vitro and in solution, respectively.

View Article and Find Full Text PDF

Background: CD133 is regarded as a marker and target for cancer stem cells (CSCs) in various types of tumors, including hepatocellular carcinoma (HCC). The expressions of CD133 and programmed cell death ligand 1 (PD-L1) in CSCs exhibit a positive feedback regulatory effect. This effect promotes CSC proliferation and immune escape, ultimately leading to tumor progression and poor prognosis.

View Article and Find Full Text PDF

Gene therapy has received great attention as a therapeutic approach to improve cardiac function post-myocardial infarction (MI), but its limitation lies in the lack of targeting. This study explored the use of ultrasound-targeted microbubble destruction (UTMD) technique to deliver β-catenin gene to the myocardium, aiming to evaluate its efficacy in preventing cardiac dysfunction post-MI. A cationic microbubble solution containing β-catenin gene pcDNA3.

View Article and Find Full Text PDF
Article Synopsis
  • Acute rejection (AR) after heart transplantation is a major complication, prompting this study to explore using ultrasound-targeted microbubbles loaded with sirolimus (SIR-MBs) to improve outcomes in a rat model.
  • The research involved comparing three treatment groups: a control, SIR-MBs with ultrasound targeting, and direct sirolimus, assessing their effects on survival, inflammation, and specific cellular pathways.
  • Results indicated that the SIR-MBs with ultrasound targeting significantly enhanced local drug delivery, reduced inflammatory response, and affected key signaling pathways and autophagy, suggesting a promising method for improving AR treatment in heart transplant patients.
View Article and Find Full Text PDF

Accelerating thrombolysis of arterial thrombus with NO-MBs UTMD therapy.

Eur J Pharm Biopharm

December 2024

Department of Ultrasonography, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province, China; The Department of Medical Ultrasound, First Affiliated Hospital of Shenzhen University, Second People's Hospital of Shenzhen, Guangdong Province, China. Electronic address:

Article Synopsis
  • Arterial thrombotic disease is a significant health issue, and nitric oxide (NO) can help delay thrombosis and tissue damage, but its systemic delivery poses challenges.
  • A novel approach using lipid microbubbles filled with NO (NO-MBs) and ultrasound-targeted microbubble destruction (UTMD) allows for targeted, real-time delivery of NO and has shown promising results in accelerating thrombolysis.
  • The treatment demonstrated strong biosafety and effectively reduced inflammation and oxidative stress associated with thromboembolism, indicating its potential for treating arterial thrombotic diseases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!